Breaking News

AAIPharma Names Analytical Labs EVP

December 12, 2012

Shirazi responsible for the Wilmington and Durham labs

Dean Shirazi, Ph.D. has been promoted to executive vice president of analytical laboratories at AAIPharma Services Corp. Dr. Shirazi has been with the company for 20 years and has helped to excel analytical chemistry and product development, most recently as vice president of analytical development. In his new role, he will have responsibilities for the Wilmington and Durham analytical laboratories.
 
Dr. Shirazi is a recognized expert in multiple types of liquid chromatography and gas chromatography, having authored more than 50 publications in scientific journals and a reference book in chromatography.
 
"The tenured analytical teams have long been the cornerstone of AAIPharma," said Patrick Walsh, chief executive officer. "As we continue to add new analytical capabilities in our new Wilmington Technology Center, Dr. Shirazi's analytical and regulatory expertise continues to be instrumental in coordinating our growth strategy."
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain

  • API Sourcing Trends

    API Sourcing Trends

    Kristin Brooks, Contract Pharma||March 19, 2015
    Ed Price of PCI Synthesis addresses trends, regulatory and supply chain hurdles, and quality concerns

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent

  • Biopharma CMO Market Trends

    Biopharma CMO Market Trends

    Tim Wright, Editor||June 2, 2016
    Continued strong growth in biopharma industry is being driven by biosimilars

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.